Jane Street Group, LLC Gilead Sciences, Inc. Call Options Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $29.5 Million - $37.3 Million	443,600 New	443,600 $37.2 Million
Q1 2022 May 17, 2022	BUY	$57.92 - $72.58 $139,008 - $174,192	2,400 Added 0.12%	2,002,100 $119 Million
Q4 2021 Feb 15, 2022	BUY	$64.88 - $73.64 $72.2 Million - $81.9 Million	1,112,800 Added 125.47%	1,999,700 $145 Million
Q3 2021 Nov 16, 2021	BUY	$67.69 - $73.03 $10.8 Million - $11.7 Million	160,100 Added 22.03%	886,900 $62 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $44.5 Million - $48.6 Million	-700,500 Reduced 49.08%	726,800 $50 Million
Q1 2021 May 18, 2021	SELL	$60.0 - $68.46 $26.8 Million - $30.6 Million	-447,400 Reduced 23.87%	1,427,300 $92.2 Million
Q4 2020 Feb 17, 2021	SELL	$56.65 - $64.55 $64.9 Million - $73.9 Million	-1,145,300 Reduced 37.92%	1,874,700 $109 Million
Q3 2020 Nov 17, 2020	SELL	$62.1 - $78.08 $99.1 Million - $125 Million	-1,596,100 Reduced 34.58%	3,020,000 $191 Million
Q2 2020 Aug 17, 2020	BUY	$72.34 - $84.0 $54.1 Million - $62.8 Million	748,200 Added 19.34%	4,616,100 $355 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $220 Million - $282 Million	3,514,300 Added 993.86%	3,867,900 $289 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $15.5 Million - $17.1 Million	251,800 Added 247.35%	353,600 $23 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $7.27 Million - $8.02 Million	-116,300 Reduced 53.32%	101,800 $6.45 Million
Q2 2019 Aug 15, 2019	BUY	$61.87 - $69.38 $3.56 Million - $3.99 Million	57,500 Added 35.8%	218,100 $14.7 Million
Q1 2019 May 16, 2019	SELL	$62.53 - $70.05 $12 Million - $13.5 Million	-192,600 Reduced 54.53%	160,600 $10.4 Million
Q4 2018 Feb 15, 2019	BUY	$60.54 - $79.0 $9.37 Million - $12.2 Million	154,800 Added 78.02%	353,200 $22.1 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $3.66 Million - $4.05 Million	-51,300 Reduced 20.54%	198,400 $15.3 Million
Q2 2018 Aug 15, 2018	BUY	$64.88 - $75.68 $142,736 - $166,496	2,200 Added 0.89%	249,700 $17.7 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $7.07 Million - $8.61 Million	97,000 Added 64.45%	247,500 $18.7 Million
Q4 2017 Feb 15, 2018	SELL	$71.15 - $83.52 $2.9 Million - $3.4 Million	-40,700 Reduced 21.29%	150,500 $10.8 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $13.8 Million - $16.3 Million	191,200	191,200 $15.5 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.5 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.99 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.65 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.5 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account